Real-world data reveals higher reported GLP-1 side effects in female patients
The second of a Series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health discusses the wide-ranging issues relating to use of GLP-1 RA drug use in women.
Read original article on The Medical News →Related news
-
Are right‑brained people really more creative?
United Kingdom
-
Sudden back pain: It can develop for several reasons, expert explains
United Kingdom
-
Vitamin B12 deficiency was linked to higher fracture hazard after 50
United Kingdom
-
Studies examine tobacco use in Native communities
United Kingdom
-
CHEST releases guideline on tobacco treatment in the inpatient setting
United Kingdom
-
Too little salt may hurt memory just as badly as too much
United Kingdom
-
30 Years of Clean-Up and Monitoring Work at Closed Copper Mine Wins Honors for World’s Top Miner
United Kingdom
-
Researchers report early results from therapy designed for a single patient with a rare genetic form of ALS
United Kingdom